References
- Bodey G P, Freireich E J, Hewlett J S, Monto R W. Cytosine arabino-side (NSC-63878) therapy for acute leukemia in adults. Cancer Chemother Rep 1969; 53: 59–66
- Bodey G P, Coltman C A, Hewlett J S, Freireich E J. Progress in the treatment of adults with acute leukemia. Arch Intern Med 1976; 136: 1383–1388
- Kremer W B. Cytabarine. Ann Intern Med 1975; 82: 688
- Frei E, III, Bickers J N, Hewlett J S, et al. Dose schedule and antitumor studies or arabinosyl cytosine (NSC 63878). Cancer Res 1969; 29: 1325–1332
- Talley R W, O'Bryan R M, Tucker W G, Loo R V. Clinical pharmacology and human antitumor activity of cytosine arabinoside. Cancer 1967; 20: 809–816
- Wasserman T H, Comis R L, Goldsmith M, et al. Tabular analysis of the clinical chemotherapy of solid tumors. Cancer Chemother Rep 1975; 6: 399–419
- Atkins J, Muss H, Capizzi R, et al. A phase I study of high dose ara-C in patients with solid tumors. Proc Am Soc Clin Oncol 1984; 3: 1
- Kirshner J, Detosantos R, Ziegler P, et al. Phase I/II study or high dose ara-C in solid tumors. Proc Am Soc Clin Oncol 1984; 3: 44
- Bergerat J-P, Drewinko B, Corry P, et al. Synergistic lethal effect of cis-dichlorodiammineplatinum and l-β-D-arabinofuranosylcy-tosine. Cancer Res 1981; 41: 25–30
- Kyriazis A P, Kyriazis A A, Yagoda A. Enhanced therapeutic effect of cis-diamminedichloroplatinum (II) against nude mouse grown human pancreatic adenocarcinoma when combined with 1-β-D-arabinofuranosylcytosine and caffeine. Cancer Res 1985; 45: 6083–6087
- Kyriazis A P, Kyriazis A A, McCombs W B, Kereiakes J G. Biological behavior of human malignant tumors grown in nude mice. Cancer Res 1981; 41: 3945–4000
- Kyriazis A A, Kyriazis A P, McCombs W B, Peterson W C. Morphological biological and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and the nude mouse. Cancer Res 1984; 44: 3947–4005
- Kyriazis A P, Yagoda A, Kereiakes J G, et al. Experimental studies on the radiation modifying effect of cis-diaminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice. Cancer 1983; 52: 452–457
- Scher H I, Ahmed T, Yagoda A, et al. Experimental studies and phase II trial of bisantrene in advanced urothelial malignancies. Cancer Invest 1985; 3: 123–127
- Kyriazis A P, Yagoda A, Kyriazis A A, Fogh J. Response of nude mouse-grown urothelial cancer to cis-diamminedichloroplatinum (II) Diamine [1,1-cyclobutanedicarboxylato (2-)-0, 0′ platinum] and mitoguazone dihydrochloride. Cancer Res 1985; 45: 2012–2015
- Kyriazis A P, Kyriazis A A, Yagoda A. Time dependence of the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) on human urothelial cancer grown in nude mice. Cancer Invest 1986; 4: 217–222
- Kyriazis A P, Yagoda A, Kyriazis A A, et al. Response to ionizing radiation of human bladder transitional cell carcinomas grown in the nude mouse. Exp Cell Biol 1985; 53: 281–286
- Kyriazis A A, Kyriazis A P. Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation. Cancer Res 1980; 40: 4509–4511
- Attia M A, Weiss D W. Immunology of spontaneous mammary carcinomas in mice V. Acquired resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 1966; 26: 1787–1800
- Ho D HW, Frei E, III. Clinical pharmacology of 1-β-D-arabinofuranosylcytosine. Clin Pharmacol Ther 1971; 12: 944–954
- Van Prooijen, Rix, Klein E VD, Haanen C. Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharmacol Ther 1977; 21: 744–750
- Pfeifle C E, King M E, Howell S B. Pharmacokinetics and clinical efficacy of intraperitoneal cytabarine treatment of advanced ovarian cancer. Proc Am Soc Clin Oncol 1983; 2: 150
- King M E, Pfeifle C E, Howell S B. Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma. J Clin Oncol 1984; 2: 662
- Markman M, Howell S B, Pfeifle C E, et al. Intraperitoneal (IP) chemotherapy with high dose cisplatin (DDP) and cytabarine (ara-C) in patients with refractory ovarian carcinoma and other malignancies. Am Soc Clin Oncol 1984; 3: 165